Objectives

1.  Identify key guideline recommendations
2. Discuss the risks and consequences of overcorrection
3. Describe recent and future studies of severe hyponatremia treatment

4. Define Osmotic Demyelination Syndrome (ODS)

5. Describe recent and future studies of severe hyponatremia treatment

6. Describe the roles of the members of the health care team in their respective responsibilities for quality care

Faculty

Anthony Poindexter, MD
Nephrologist
 

Session date: 
Friday, November 2, 2018 - 12:00pm to 1:00pm
Location: 
Baystate Medical Center
759 Chestnut St
Chicopee/Agawam Room
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.